Cytosorbents Corporation
CTSO
|
|
| |
|
| Trading Volume | 100,644 |
|
|
2.58 - 0.75 |
| Market Cap Full | $ 44.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -0.7% | -15% | 117.4% | -23.9% |
| Q2 | - | -13.2% | 6.5% | -31.4% |
| Q3 | - | -16.1% | -47.6% | -37.9% |
| Q4 | - | 3.6% | -37.6% | 14% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -9 | -5.1 | -1.6 | -13.5 | 10 | -14 | 54 | -16.1 | - | - | - | - |
| 2023 | |||||||||||
| 84.5 | 7.7 | 9.4 | -27.3 | 21.2 | 20.9 | -0.6 | -27.7 | -27.1 | -18.1 | -22.1 | -7.5 |
| 2022 | |||||||||||
| -11.2 | 4 | -17.6 | -34.2 | -8.1 | 13.5 | 4.1 | -16.7 | -28.4 | 37.5 | -25.1 | 10.7 |
| 2021 | |||||||||||
| 34.5 | -13 | -7.9 | 6.6 | -12.5 | -6.7 | 1.5 | 24.9 | -15.2 | -27.5 | -16.7 | -14.6 |
| 2020 | |||||||||||
| 21.4 | 29.7 | 28.2 | 10.7 | 19.3 | -3 | -3.3 | -11.9 | -5.5 | -4.1 | 10.2 | -4.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.2 | -0.1 | -0.1 |
| Q2 | -0.1 | -0.3 | -0.1 | -0.1 |
| Q3 | -0.2 | -0.3 | -0.2 | -0 |
| Q4 | 0 | -0 | -0.2 | 0 |
| A | -0.52 | -0.8 | -0.6 | -0.2 |